New Blood Test Predicts Which CV Patients Will Develop Severe Case

njbr

The blood test works by measuring the levels of two molecules that send messages to the body’s immune system and control inflammation. One of these molecules, interleukin (IL)-6, is pro-inflammatory, and a different one, called IL-10, is anti-inflammatory. The levels of both are altered in severe Covid-19 patients.

The measurement, called the Dublin-Boston score, is designed to enable clinicians to make more informed decisions when identifying patients who may benefit from therapies, such as steroids, and admission to intensive care units.

Until this study, no Covid-19-specific prognostic scores were available to guide clinical decision-making. The Dublin-Boston score can now accurately predict how severe the infection will be on day seven after measuring the patient’s blood for the first four days.

Comments (2)
No. 1-2
Eddie_T
Eddie_T

Looks good.

Carl_R
Carl_R

Perhaps it is more accurate than prior measures, but to say that doctors has no measures at all from which to project the direction Covid would take is not really correct.